RichardLouisDunbarMD

Internal Medicine • Philadelphia, PA

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Dunbar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dunbar's full profile

Already have an account?

Office
39th and Market Streets
Phi Suite 2a
Philadelphia, PA 19104
Phone+1 215-662-9990

Fax+1 215-615-0500

Education & Training

Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1997 - 2000
Virginia Commonwealth University School of MedicineClass of 1997

Certifications & Licensure

PA State Medical License 2003 - 2024
VA State Medical License 1998 - 2004

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study Start of enrollment: 2008 Jun 01
Completed
Phase 2
Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Start of enrollment: 2009 Feb 01
Completed
Phase 4
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis Start of enrollment: 2010 Nov 01
Completed
Not Applicable
Effects of Niacin On Fatty Acid Trapping Start of enrollment: 2012 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

5 citations
Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.
Maureen Sampson, Anna Wolska, Marcelo Amar, Masako Ueda, Richard Dunbar
Clinical Chemistry. 2022-10-06
30 citations
Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia
Zahid Ahmad, Robert Pordy, Daniel J. Rader, Daniel Gaudet, Shazia Ali
Journal of the American College of Cardiology. 2021-07-13
2 citations
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients.
Anne C. Goldberg, Richard L. Dunbar, Linda C. Hemphill, Stephan P. Babirak, Gerald Wilson
Journal of Clinical Lipidology. 2020-08-18

Lectures

Sizing Up Extreme Triglyceridemia: How to Spot a Coyote in a Wolf's Clothing
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/20/2018

Press Mentions

Injectable Regeneron Biologic Therapy Reduces Triglycerides, CholesterolNovember 15th, 2016
Injectable Biologic Therapy Dramatically Reduces TriglyceridesNovember 14th, 2016

Grant Support

Niacin'S Effect On Fatty Acids And Inflammatory Markers (Nefa-Im)National Heart, Lung, And Blood Institute2009–2011